152 related articles for article (PubMed ID: 34098405)
1. Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk.
Krilis M; Qi M; Ioannou Y; Zhang JY; Ahmadi Z; Wong JWH; Vlachoyiannopoulos PG; Moutsopoulos HM; Koike T; Sturgess AD; Chong BH; Krilis SA; Giannakopoulos B
J Autoimmun; 2021 Aug; 122():102675. PubMed ID: 34098405
[TBL] [Abstract][Full Text] [Related]
2. The role of thrombospondin-1 in the pathogenesis of antiphospholipid syndrome.
Patsouras M; Tsiki E; Karagianni P; Vlachoyiannopoulos PG
J Autoimmun; 2020 Dec; 115():102527. PubMed ID: 32709480
[TBL] [Abstract][Full Text] [Related]
3. Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.
Ioannou Y; Zhang JY; Qi M; Gao L; Qi JC; Yu DM; Lau H; Sturgess AD; Vlachoyiannopoulos PG; Moutsopoulos HM; Rahman A; Pericleous C; Atsumi T; Koike T; Heritier S; Giannakopoulos B; Krilis SA
Arthritis Rheum; 2011 Sep; 63(9):2774-82. PubMed ID: 21618459
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of β₂-glycoprotein-I plasma levels in antiphospholipid syndrome (APS).
Banzato A; Pengo V
Curr Rheumatol Rep; 2014 Jun; 16(6):424. PubMed ID: 24797512
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of purified anti-β2GPI IgG N-glycosylation associate with thrombotic, obstetric and catastrophic antiphospholipid syndrome.
Liu T; Han J; Zhang R; Tang Z; Yi G; Gong W; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Shi Y; Gu J; Ren S; Yang C; Shi H
Rheumatology (Oxford); 2022 Mar; 61(3):1243-1254. PubMed ID: 34015111
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndrome.
Kolyada A; Porter A; Beglova N
Blood; 2014 Feb; 123(7):1090-7. PubMed ID: 24277078
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome.
Patsouras MD; Sikara MP; Grika EP; Moutsopoulos HM; Tzioufas AG; Vlachoyiannopoulos PG
J Autoimmun; 2015 Dec; 65():30-7. PubMed ID: 26283469
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
9. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome.
Lopez D; Kobayashi K; Merrill JT; Matsuura E; Lopez LR
Clin Dev Immunol; 2003; 10(2-4):203-11. PubMed ID: 14768953
[TBL] [Abstract][Full Text] [Related]
10. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
[TBL] [Abstract][Full Text] [Related]
11. β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease.
Rauch J; Salem D; Subang R; Kuwana M; Levine JS
Front Immunol; 2018; 9():2836. PubMed ID: 30619248
[TBL] [Abstract][Full Text] [Related]
12. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Matsuura E; Kobayashi K; Hurley BL; Lopez LR
Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
[TBL] [Abstract][Full Text] [Related]
13. Soluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndrome.
Kolyada A; Ke Q; Karageorgos I; Mahlawat P; Barrios DA; Kang PM; Beglova N
J Thromb Haemost; 2016 Jun; 14(6):1298-307. PubMed ID: 26990752
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.
Montalvão S; Elídio PS; da Silva Saraiva S; de Moraes Mazetto B; Colella MP; de Paula EV; Appenzeller S; Annichino-Bizzacchi J; Orsi FA
Thromb Res; 2016 Dec; 148():32-37. PubMed ID: 27770664
[TBL] [Abstract][Full Text] [Related]
15. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to domain 1 of beta 2 glycoprotein I determined using a novel chemiluminescence immunoassay demonstrate association with thrombosis in patients with antiphospholipid syndrome.
Mahler M; Albesa R; Zohoury N; Bertolaccini ML; Ateka-Barrutia O; Rodriguez-Garcia JL; Norman GL; Khamashta M
Lupus; 2016 Jul; 25(8):911-6. PubMed ID: 27252269
[TBL] [Abstract][Full Text] [Related]
17. {beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome.
Sikara MP; Routsias JG; Samiotaki M; Panayotou G; Moutsopoulos HM; Vlachoyiannopoulos PG
Blood; 2010 Jan; 115(3):713-23. PubMed ID: 19805618
[TBL] [Abstract][Full Text] [Related]
18. Post-translational oxidative modification of β2-glycoprotein I and its role in the pathophysiology of the antiphospholipid syndrome.
Mirarabshahi P; Abdelatti M; Krilis S
Autoimmun Rev; 2012 Sep; 11(11):779-80. PubMed ID: 22240262
[TBL] [Abstract][Full Text] [Related]
19. Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.
Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Tormene D; Hoxha A; Fedrigo M; Simioni P
Clin Chim Acta; 2015 Jun; 446():201-5. PubMed ID: 25935129
[TBL] [Abstract][Full Text] [Related]
20. Value of isolated IgA anti-β2 -glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome.
Murthy V; Willis R; Romay-Penabad Z; Ruiz-Limón P; Martínez-Martínez LA; Jatwani S; Jajoria P; Seif A; Alarcón GS; Papalardo E; Liu J; Vilá LM; McGwin G; McNearney TA; Maganti R; Sunkureddi P; Parekh T; Tarantino M; Akhter E; Fang H; Gonzalez EB; Binder WR; Norman GL; Shums Z; Teodorescu M; Reveille JD; Petri M; Pierangeli SS
Arthritis Rheum; 2013 Dec; 65(12):3186-93. PubMed ID: 23983008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]